Colestid and Pentasa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colestid (colestipol hydrochloride) and Pentasa (mesalamine). Common drug interactions include aneurysm among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Colestid and Pentasa. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Colestid?

Colestid has active ingredients of colestipol hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 2,233 Colestid users. Check the latest studies of Colestid.

What is Pentasa?

Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. eHealthMe is studying from 23,325 Pentasa users. Check the latest studies of Pentasa.

On Jul, 26, 2026

59 people who take Colestid and Pentasa together, and have interactions are studied.

What are the common drug interactions of Colestid and Pentasa, by gender? *:

female:

Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Chest discomfort
Blood pressure decreased
Presyncope
Pulse absent
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Troponin increased
Blood pressure increased
Fall
Upper limb fracture

male:

Pneumonia
Lymphadenitis (inflammation or enlargement of a lymph node)
Abdominal pain lower
Abscess (pus)
Anxiety
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Back pain
Benign prostatic hyperplasia (benign enlargement of the prostate)
Bladder trabeculation (bladder trabeculation is characterized by a thick wall and hypertrophied muscle bundles)

What are the common drug interactions of Colestid and Pentasa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Emotional distress
Inflammatory bowel disease
Intestinal obstruction
Liver abscess (pus in liver)
Nausea (feeling of having an urge to vomit)
Vomiting

30-39:

Injection site swelling
Pain
Sensation of heaviness
Weight increased
Abdominal pain
Abdominal pain lower
Abscess (pus)
Anxiety
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Benign prostatic hyperplasia (benign enlargement of the prostate)

40-49:

Chest discomfort
Craniocerebral injury (injury to cranium and brain)
Dyspepsia (indigestion)
Dysphagia (a condition in which swallowing is difficult or painful)
Lip pain
Rash pruritic (redness with itching)
Swelling
Syncope (loss of consciousness with an inability to maintain postural tone)
Lymphadenitis (inflammation or enlargement of a lymph node)
Abdominal discomfort

50-59:

Cough
Migraine (headache)
Heart rate decreased
Nausea (feeling of having an urge to vomit)
Pneumonia
Abdominal discomfort
Alanine aminotransferase increased
Alopecia (absence of hair from areas of the body)
Anorectal discomfort
Anxiety

60+:

Acidosis (build-up of carbon dioxide in the blood)
Cardiac failure congestive
Joint swelling
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Therapeutic response decreased (less preventive response)
Vision blurred
Dyspnoea (difficult or laboured respiration)
Hypokalaemia (low potassium)
Hypoxia (low oxygen in tissues)
Influenza

What are the existing conditions these people have? *

Pain: 14 people, 23.73%
Diarrhea: 6 people, 10.17%
Rickets (softening of bones): 4 people, 6.78%
Iron Deficiency Anaemia: 4 people, 6.78%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Colestid and Pentasa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously